By Hamza Faisal
Chinese artificial intelligence startup Moonshot is expanding into Singapore, with a new sales role listed on the company's LinkedIn page this week — the first visible sign of an on-the-ground commercial push outside mainland China.
The job posting, dated Tuesday, seeks applicants who have sales, venture capital, consulting, product or engineering experience and can "translate early wins into scalable revenue, strategic partnerships, and market presence." Business registry records show Moonshot already has a business entity in Singapore, incorporated in July 2023 and renamed to Novascent in June 2026.
A legal foothold, now a real operation
Moonshot has held the Singapore entity for more than three years, but until now there has been little public evidence of active operations there. The hiring move suggests the Beijing-based company is moving from paperwork to people: building commercial relationships, chasing enterprise deals, and establishing market presence in Southeast Asia.
The company did not immediately respond to a request for comment on Wednesday about its Singapore plans, according to Reuters, which first reported the posting.
Kimi K3 sets the stage
The expansion comes just months after Moonshot released its Kimi K3 model in July, which the company described as the world's largest open-weight AI system and said delivers performance approaching that of Anthropic's models. The release cemented Moonshot's place among the handful of Chinese labs considered credible challengers to the American frontier players.
Moonshot's backers include Tencent, Meituan and China Mobile, giving it both capital and distribution muscle at home. But with competition among Chinese AI firms intensifying beyond their home market — DeepSeek, Alibaba's Qwen and others all courting overseas developers and enterprise buyers — a Singapore base offers a neutral, English-speaking springboard into Southeast Asia and beyond.
Singapore's AI gravity keeps growing
The move is also a vote of confidence in Singapore's positioning as the region's AI hub. The city-state has spent years courting AI research labs, data-centre investment and startup headquarters with grants, compute subsidies and a business-friendly regulatory posture — and Chinese labs are increasingly part of that inbound flow.
Moonshot is separately reported to be targeting a Hong Kong IPO as early as the first quarter of 2027 at a valuation near $50 billion. An international commercial footprint in Singapore would be a natural piece of that story to tell public-market investors: not just a Chinese model lab, but a global AI business with revenue geography to match.
By Hamza Faisal
